Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nasdaq Nordic is a leading operator of financial exchanges in Northern Europe and the Baltics, serving as a critical infrastructure provider for the region's capital markets. While not a life sciences company itself, it is a premier global listing venue for European biotechnology, medtech, and pharmaceutical companies, particularly through its Stockholm and Copenhagen hubs. The organization provides trading, clearing, settlement, and data services across various asset classes, including equities and derivatives. Nasdaq Nordic's First North Growth Market is specifically recognized for its role in supporting early-stage healthcare companies in accessing public capital, making it one of the most active ecosystems for life science IPOs in the world.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nasdaq Nordic.